United States · FDA National Drug Code directory
Actoplus Met
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-158_8bacb433-92b6-4285-9ed3-b49e46ec63fc
- Product NDC
- 64764-158
- Form
- TABLET, FILM COATED
- Composition / generic term
- pioglitazone and metformin hydrochloride
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20050829
- Source listing expiry
- 20271231
Source-listed ingredients
- PIOGLITAZONE HYDROCHLORIDE — 15 mg/1
- METFORMIN HYDROCHLORIDE — 850 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-158-18) · 64764-158-18
- 4 CARTON in 1 TRAY (64764-158-41) / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 BLISTER PACK · 64764-158-41
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-158-60) · 64764-158-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →